| abstract |
FIELD: medicine.SUBSTANCE: method and a kit for treating cancer expressing IGF-1R are disclosed. An anti-IGF-1R antibody and an antibody-drug conjugate of formula Ab-(L-D)or a pharmaceutically acceptable salt thereof are used.EFFECT: proposed group of inventions enables to determine the status of IGF-1R cancer by using a first antibody and use a second antibody as ADC (antibody-drug conjugate) for treating cancer.11 cl, 39 dwg, 18 tbl, 27 ex |